Warsaw, Poland

Robert Kawęcki

This inventor holds 1 USPTO granted patent. Top assignees: Instytut Chemii Organicznej Polskiej Akade, Narodowy Instytut Lekow. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert Kawęcki. Retrieved from https://idiyas.com/inventor/robert-kawęcki

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Robert Kawęcki in Camptothecin Derivatives

Introduction

Robert Kawęcki is a notable inventor based in Warsaw, Poland. He has made significant contributions to the field of medicinal chemistry, particularly through his work on camptothecin derivatives. His innovative approach has led to advancements in anti-neoplasm therapy, showcasing the potential of these compounds in medical applications.

Latest Patents

Kawęcki holds a patent for "Derivatives of camptothecin, a method of producing them and their use." This invention focuses on water-soluble derivatives of camptothecin, detailing their synthesis and potential uses. These compounds exhibit preferable biological properties, making them valuable in the treatment of cancer.

Career Highlights

Throughout his career, Robert Kawęcki has worked with esteemed institutions such as the Institute of Organic Chemistry of the Polish Academy of Sciences and the National Institute of Medicines. His research has been pivotal in exploring the therapeutic applications of camptothecin derivatives.

Collaborations

Kawęcki has collaborated with notable colleagues, including Lech Kozerski and Beata Naumczuk. Their combined expertise has contributed to the advancement of research in the field of medicinal chemistry.

Conclusion

Robert Kawęcki's work on camptothecin derivatives represents a significant advancement in cancer therapy. His innovative contributions continue to influence the field of medicinal chemistry and offer hope for improved treatment options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…